To further determine whether inhibition of the IRE1α/XBP1 pathway in p53-deficient cells suppresses tumor growth, mice were engrafted with HCT116 p53+/+ and HCT116 p53−/− cells, and the effect of STF-083010 on tumor growth was observed. Here, TP53 is linked to neoplasm.